Contractile effects of angiotensin and endothelin in failing and non-failing human hearts

International Journal of Cardiology

Volumn 114, Issue 1, 2007, Pages 34-40

  Möllmann, Helge ^a   Schmidt Schweda, Stephan ^b   Nef, Holger ^a   Möllmann, Susanne ^a   Burstin, Johannes V ^c   Klose, Stefan ^c   Elsässer, Albrecht ^a   Holubarsch, Christian J F ^c  

^a KERCKHOFF HEART CENTER   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiotensin II; Endothelin 1; Heart failure; Isolated cardiomyocytes; Subcellular mechanism

Indexed keywords

AMILORIDE; ANGIOTENSIN II; ENDOTHELIN 1; PROTEIN KINASE C;

ADULT; ARTICLE; CELL ISOLATION; CELL PH; CELL SIZE; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; MALE; MUSCLE FIBER CONTRACTION; PRIORITY JOURNAL;

ANGIOTENSIN I; ENDOTHELIN-1; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MYOCYTES, CARDIAC;

EID: 33751226264     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.01.004     Document Type: Article

References (38)

1. Takanashi M., and Endoh M. Characterization of positive inotropic effects of endothelin on mammalian ventricular myocardium. Am J Physiol 261 (1991) H611-H619
2. Pieske B., Beyermann B., Breu V., et al. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circ 99 (1999) 1802-1809
3. MacCarthy P.A., Grocott-Mason R., Prendergast B.D., and Shah A.M. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation 101 (2000) 142-147
4. Lerman A., Kubo S., Tschumperlin L., and Burnett J. Plasma endothelin concentrations in human with endstage heart failure and after heart transplantation. J Am Coll Cardiol 20 (1992) 849-853
5. Pönicke K., Vogelsang M., Heinroth M., et al. Endothelin receptors in the failing and nonfailing human heart. Circ 97 (1998) 744-751
6. Schunkert H., Dzau V., Tang S., Hirsch A., Apstein C., and Lorell B. Increased cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 86 (1990) 1913-1920
7. Regitz-Zagrosek V., Friedel N., Heymann A., et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circ 91 (1995) 1461-1471
8. Lindpainter K., and Ganten D. The cardiac renin-angiotensin system. Circ Res 68 (1991)
9. Baker K.M., and Aceto J.A. Characterization of avian angiotensin II cardiac receptors: coupling to mechanical activity and phosphoinositide metabolism. J Mol Cell Cardiol 21 (1989) 375-382
10. Dempsey P.J., McCallum Z.T., Kent K.M., and Cooper T. Direct myocardial effects of angiotensin II. Am J Physiol 220 (1971) 477-481
11. Moravec C., Schluchter M., Paranaudi L., et al. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circ 82 (1990) 1973-1984
12. Allen I.S., Cohen N.M., Dhallan R.S., Gaa S.T., Lederer W.J., and Rogers T.B. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms. Circ Res 62 (1988) 524-534
13. Baker K.M., and Singer H.A. Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production. Circ Res 62 (1988) 896-904
14. Holubarsch C., Hasenfuss G., Schmidt-Schweda S., et al. Angiotensin I and II exerts inotropic effects in atrial but not in ventricular human myocardium: an in vitro study under physiological experimental conditions. Circ 88 (1993) 1228-1237
15. Brutsaert D., Fransen P., Andries L., DeKeulenaer G., and SV S. Cardiac endothelium and myocardial function. Cardiovasc Res 38 2 (1998) 281-290
16. Furuyama M., Haneda T., Ikeda J., et al. Responses of atrium and ventricle to sustained sympathetic nerve stimulation. Am J Physiol 261 (1991) H1889-H1894
17. Johnston B.D. Nerve endings in the human endocardium. Am J Anat 122 (1968) 621-629
18. Rump L., Schwertfeger E., Schaible U., Fraedrich G., and Schollmeyer P. Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res 74 3 (1994) 434-440
19. Mulieri L., Hasenfuss G., Ittleman F., Blanchard E., and Alpert N. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res 65 (1989) 1441-1444
20. Booz G.W., and Baker K.M. Protein kinase C in angiotensin II signalling in neonatal rat cardiac fibroblasts. Role in the mitogenic response. Ann N Y Acad Sci 752 (1995) 158-167
21. Lefroy D., Crale T., Monte del F., et al. Angiotensin II and contraction of isolated myocytes from human, guinea pig and infarcted rat hearts. Am J Physiol 270 (1996) H2060-H2069
22. Wang Q.D., and Nygren E. Various inotropic effects of angiotensin II in postischaemic rat hearts depending on ischaemic time with possible involvement of protein kinase C. Acta Physiol Scand 178 (2003) 189-196
23. Petroff M.G., Aiello E.A., Palomeque J., Salas M.A., and Mattiazzi A. Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium. J Physiol 529 Pt. 1 (2000) 189-203
24. Perez N.G., Villa-Abrille M.C., Aiello E.A., Dulce R.A., Cingolani H.E., and Camilion de Hurtado M.C. A low dose of angiotensin II increases inotropism through activation of reverse Na(+)/Ca(2+) exchange by endothelin release. Cardiovasc Res 60 (2003) 589-597
25. Meyer M., Lehnart S., Pieske B., et al. Influence of endothelin-1 on human atrial myocardium-myocardial function and subcellular pathways. Basic Res Cardiol 91 (1996) 86-93
26. Moravec C., Reynolds E., Stewart R., and Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 159 (1989) 14-18
27. Talukder M.A., Norota I., Sakurai K., and Endoh M. Inotropic response of rabbit ventricular myocytes to endothelin-1: difference from isolated papillary muscles. Am J Physiol Heart Circ Physiol 281 (2001) H596-H605
28. Fabiato A., and Fabiato F. Effects of pH in the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiac and skeletal muscles. J Physiol (Lond) 276 (1978) 233-255
29. Allen D., and Orchard C. The effects of changes of pH on intracellular calcium transients in mammalian myocardium. J Physiol 335 (1983) 555-567
30. Krämer B., Smith T., and Kelly R. Endothelin and increased contractility in adult rat ventricular myocytes. Role of intracellular alkalosis induced by activation of the protein kinase c-dependent NHE. Circ Res 68 (1991) 269-279
31. Chu L., Norota I., Yomogida S., Ishii K., and Endoh M. Differential inotropic effects of endothelin-1, angiotensin II, and phenylephrine induced by crosstalk with cAMP-mediated signaling process in dog ventricular myocardium. J Pharmacol Sci 96 (2004) 199-207
32. Peters S.L., Sand C., Michel M.C., Pfaffendorf M., and Van Zwieten P.A. A mitogen-activated protein kinase is involved in the inotropic but not chronotropic actions of adrenoceptor agonists and endothelin-1. Naunyn Schmiedebergs Arch Pharmacol 366 (2002) 189-191
33. Ihara M., Noguchi K., Saeki T., et al. Biological profiles of highly potent novel endothelin antagonists selective for the ET A-receptor. Life Sci 50 (1991) 247-255
34. Kiowski W., Sütsch G., Hunziker P., et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346 (1995) 732-736
35. Coletta A., Thackray S., Nikitin N., and Cleland J.G. Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 and 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail 4 (2002) 381-388
36. Anand I., McMurray J., Cohn J.N., et al. Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 347-354
37. Grover G., Sleph P., Fox M., and Trippodo N. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther 263 3 (1992) 1074-1082
38. Grover G., Dzwonczyk S., and Parham C. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 27 9 (1993) 1613-1618